Health Condition 1: E039- Hypothyroidism, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Age- 18-60 years. 2)Patients of both sexes. 3)TSH levels greater than/equal to 4.6 mIU/L to greater than/equal to 19.9 mIU/L with or without thyroxine. 4)Patients having clinical symptoms of Medoroga like- Ashakta sarvakarmasu,kshudra shwasa, trisha ,moha, Swapna, kathana sadana ,kshudha, sweda , daurgandhya, alpa prana, alpa maithuna, udara vriddhi etc. 5)Patients having clinical symptoms of hypothyroidism like - Weakness, Fatigue, Muscle ache, Muscle weakness, Breathlessness, Lethargy, Hoarseness of voice, loss of libido, Menstrual abnormality, Puffiness of the face and eyelids, Peripheral edema, Weight gain, Dry coarse skin, Constipation, Hair loss, Feeling cold.
Exclusion criteria
Exclusion criteria: 1)Patient having TSH level greater than 19.9 mIU/ L. 2)Recent thyroid surgery or radio-iodine (within 12 months). 3)Uncontrolled blood sugar, hypertension. 4)Prior clinical diagnosis of dementia. 5)Recent acute coronary syndrome, including myocardial infarction or unstable angina. 6)Plan to move out of the region in which the trial is being conducted within the next 2 years (proposed minimum time of study) 7)Suffering from diseases like HIV, tuberculosis, encephalopathy, goiter, other endocrine disorders and other autoimmune disorders. 8)Pregnancy, lactation. 9)Any other condition/medication which interfere with the intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Change in symptoms of Medoroga. 2)Change in serum TSH levels. 3)Change in symptoms of hypothyroidism and Fatigue symptoms.Timepoint: 0th day, 18th day, 33rd day, follow up after completion of study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall improvement in health-related quality of life.Timepoint: 0th day, 18th day, 33rd day, follow up after completion of study. | — |
Countries
India
Contacts
All India Institute of Ayurveda